Companies

Arena Pharmaceuticals, Inc.

NASDAQ: ARNA
$99.99
â–² $0.00 (+0.00%) today
Markets open · 3:41pm ET

ARNA Coverage

Page 6
10:42am ET
Health and Healthcare

Arena Files for European Drug Review (ARNA, VVUS, OREX)

Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) announced that its application to sell its lorcaserin weight-loss drug in Europe has been accepted by the Europe Medicines Agency. This is the first step…

Paul Ausick
9:22am ET
Investing

Analyst Sees Much More VIVUS Upside (VVUS, OREX, ARNA)

VIVUS, Inc. (NASDAQ: VVUS) is literally killing short sellers this morning after scoring an FDA panel backing with the recommendation to approve Qnexa as a treatment against obesity.  This will likely be an…

Jon C. Ogg